If this raises more questions in this controversial field, I have succeeded!
Sincerely,
Anand N. Malaviya, MD, FRCP, Master-ACR
Department of Rheumatology
Indian Spinal Injuries Center
Vasant Kunj, New Delhi, India
ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
References
- Henkel G. To give or not to give? Debate continues over place of glucocorticoids in RA management. The Rheumatologist. 2015 March;9(3):37–39.
- Enas EA, Mohan V, Deepa M, et al. The metabolic syndrome and dyslipidemia among Asian Indians: A population with high rates of diabetes and premature coronary artery disease. J Cardiometab Syndr. 2007 fall;2(4):267–275.
- Joshi SR, Parikh RM. India—Diabetes capital of the world: Now heading towards hypertension. J Assoc Physicians India. 2007 May;55: 323–324.
- Zaheer Q, Malaviya A, Negi P. Mini-pulses of methylprednisolone (MP-P) synchronised with weekly low dose methotrexate in the treatment of rheumatoid arthritis (RA): Could this be the best way to use glucocorticoids among Indian patients? Indian Rheumatology Association Annual Meeting 26th Iracon. Bhubaneswar, Oddisa; Poster presentation. 2010.
- Malaviya AN. ARHP Session C54: Rheumatoid arthritis management: Views from around the world. Conventional DMARDs or biologics: A developing world perspective. ACR/ARHP Annual Meeting. 2013 Oct 25–30.